BioMarin Pharmaceutical (BMRN): Q4 EPS of $0.05, beats by $0.04. Revenue of $87M (-12.3%) vs....

|About: BioMarin Pharmaceutical Inc. (BMRN)|By:, SA News Editor
BioMarin Pharmaceutical (BMRN): Q4 EPS of $0.05, beats by $0.04. Revenue of $87M (-12.3%) vs. $86M. Guides FY10 revenue in-line. Shares +0.6% AH. (PR)